Metastatic Prostate Cancer (with Prostate-Specific Antigen of 9996) Presenting as Obstructive Jaundice
- 1 February 2000
- journal article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 319 (2) , 118-22
- https://doi.org/10.1097/00000441-200002000-00009
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Serum percent free prostate-specific antigen in metastatic prostate cancerUrology, 1998
- A case of flutamide-induced acute cholestatic hepatitis: a case reportYonsei Medical Journal, 1996
- Flutamide HepatotoxicityJournal of Urology, 1996
- Cholestatic hepatitis following flutamideDigestive Diseases and Sciences, 1993
- Is Prostate Specific Antigen of Clinical Importance in Evaluating Outcome after Radical ProstatectomyJournal of Urology, 1993
- Case report: Accumulation of 99mTc-hydroxymethylene diphosphonate by liver metastases of prostatic adenocarcinomaClinical Radiology, 1993
- Metastatic prostate cancer presenting as obstructive jaundiceUrology, 1992
- Flutamide-induced liver failureJournal of Hepatology, 1990
- Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign HyperplasiaJournal of Urology, 1990
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987